Elevance Health (ELV) Net Cash Flow (2010 - 2026)

Elevance Health (ELV) has 17 years of Net Cash Flow data on file, last reported at $578.0 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 45.42% year-over-year to $578.0 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 19.74% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 34.13% from the prior year.
• Net Cash Flow for Q2 2026 stood at $578.0 million, up from $175.0 million in the prior quarter.
• Over the last five years, Net Cash Flow for ELV reached as high as $2.8 billion in Q1 2023 and fell as low as -$4.4 billion in Q4 2023.
• Historically, Net Cash Flow has averaged $303.1 million across 5 years, with a median of $388.5 million in 2022.
• Across the five-year window, Net Cash Flow surged 935.04% in 2022 and plunged 195.49% in 2023, its largest moves.
• Year by year, Net Cash Flow stood at -$1.5 billion in 2022, then plunged by 195.49% to -$4.4 billion in 2023, then jumped by 110.83% to $476.0 million in 2024, then jumped by 64.71% to $784.0 million in 2025, then retreated by 26.28% to $578.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $578.0 million in Q2 2026, $175.0 million in Q1 2026, and $784.0 million in Q4 2025.